Medical News

RSS

Study finds high sugar content in toddler and baby food products

Fifty three percent of food products specifically targeted to babies and toddlers in Canadian grocery stores have an excessive proportion-more than 20 per cent-of calories coming from sugar, according to a new study by University of Calgary professor Charlene Elliott.

29 Jun 2010

Young breast cancer patients more likely to discontinue hormone therapy

A new study of nearly 8,800 women with early-stage breast cancer found that fewer than half - approximately 49 percent - completed their full regimen of hormone therapy according to the prescribed schedule.

29 Jun 2010

New research project to develop reliable and cost-effective virtual autopsies

A new research project at the University of Leicester is set to play a vital role in continuing research into viable alternatives to invasive autopsies, which many families find to be unpleasant.

29 Jun 2010

New equation offers accurate estimation of peak heart rate for women

Women who measure their peak heart rates for exercise will need to do some new math as will physicians giving stress tests to patients.

29 Jun 2010

Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act signed into law

The President signed into law on Friday, June 25, 2010, The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act. The bill was approved by the U.S. House of Representatives by a vote of 417 to 1. The Senate had earlier approved the measure.

29 Jun 2010

Marcadia, Eli Lilly sign development, license agreement for short-acting glucagon program

Marcadia Biotech, Inc. and Eli Lilly and Company today announced that the companies have signed a development and exclusive license agreement for Marcadia's short-acting glucagon program, covering glucagon analogs that may provide greater convenience and ease-of-use than the current recombinant glucagon for the treatment of severe hypoglycemia. The program includes MAR531, a glucagon analog that is in preclinical development at Marcadia, as well as related backup compounds.

29 Jun 2010

High-phenolic-content olive oil modifies genes that promote inflammation

Health conscious consumers have long known that virgin olive oil is a good choice when it comes to preparing meals and dipping breads. Now, a team of researchers, including one with the Agricultural Research Service (ARS), has found that phenolic components in olive oil actually modify genes that are involved in the inflammatory response.

29 Jun 2010

Literature review discusses herniated disks and treatment options for low back pain

A literature review, led by Dr. Joseph Lee, published in the June 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) suggests that a herniated disk is one of the most frequent causes of low back and leg pain in adults, but surgery is not for everyone. Between 60 and 80 percent of people will experience low back pain at some point in their lives

29 Jun 2010

MGH, Iacocca Foundation complete Phase I BCG clinical trial in type 1 diabetes

Massachusetts General Hospital (MGH) and the Iacocca Foundation announce today the completion of the Phase I BCG clinical trial in type 1 diabetes, as well as the submission of all safety reports to the U.S. Food and Drug Administration (FDA) and the MGH data safety monitoring boards. Plans for the Phase II clinical study, which will continue the investigation of bacillus Calmette-Guerin (BCG) vaccination as a treatment for people with existing type 1 diabetes, are actively underway.

29 Jun 2010

Rubella epidemic played a major role in shifting public attitudes toward abortion laws

Ten years before the 1973 Supreme Court decision legalizing abortion - which likely will be a focus of Senate confirmation questions for Supreme Court nominee Elena Kagan next week - German measles probably played the biggest part in starting to shift public attitudes about the criminal abortion laws, University of Illinois historian Leslie J. Reagan says in a new book.

29 Jun 2010

Rosiglitazone associated with increased risk of serious cardiovascular events compared with pioglitazone

A new study published online today by JAMA shows that among patients age 65 years and older, rosiglitazone (a medication for treating Type 2 diabetes) is associated with an increased risk of stroke, heart failure, and all-cause mortality (death) when compared with pioglitazone (another medication for diabetes). The study was published online today in advance of an upcoming Food and Drug Administration meeting that will review the safety of rosiglitazone. The paper will appear in the July 28 print issue of JAMA.

29 Jun 2010

Hospira announces intention to complete tender offer for Javelin's outstanding common stock shares

Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced its intention to complete the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc., upon its currently scheduled expiration at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010).

29 Jun 2010

Study finds no link between internet and gambling addictions, but affected individuals have common psychological profiles

A study of university students found no overlap between those reporting excessive Internet use and those with problem gambling.

29 Jun 2010

Bicycling and brisk walking associated with less weight gain in obese, premenopausal women

Bicycling and brisk walking are associated with less weight gain among pre-menopausal women, especially those who are overweight and obese, according to a report in the June 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Additionally, the report finds that slower walking does not appear to offer the same benefits as brisk walking.

29 Jun 2010

APP to market Anastrozole 1 mg tablets in U.S.

Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Anastrozole tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.

29 Jun 2010

Failed ACL surgeries are more common than previously thought

Nick Van Erp, active in soccer since elementary school and lacrosse since junior high, tore the anterior cruciate ligament in his knee during a spring lacrosse game his freshman year of high school. His injury, caused by stepping into a pothole and hyper-extending his knee, required surgical repair, ending his season prematurely and the remainder of his high school sports career.

29 Jun 2010

G8 nations commit $5B for maternal, child health; Additional $2.3B committed from other countries, foundations

G8 nations, plus other countries and private organizations, have committed at total of $7.3 billion to improve maternal and child health in the developing world, Canadian Prime Minister Stephen Harper said on Friday at the group's summit in Canada's Muskoka region, All Headline News reports (6/26).

29 Jun 2010

EpiCept requests FDA priority review of Ceplene NDA for AML

EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.

29 Jun 2010

Endometriosis can affect women's work productivity

The first worldwide study of the societal impact of endometriosis has found a significant loss of work productivity among those women who suffer from the condition, a researcher told the 26th annual meeting of the European Society of Human Reproduction and Embryology today (Monday).

29 Jun 2010

BioAlliance Pharma presents abstracts on Loramyc, clonidine Lauriad at MASCC/ISOO 2010 symposium

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.

29 Jun 2010

Medical News

Study finds high sugar content in toddler and baby food products

Young breast cancer patients more likely to discontinue hormone therapy

New research project to develop reliable and cost-effective virtual autopsies

New equation offers accurate estimation of peak heart rate for women

Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act signed into law

Marcadia, Eli Lilly sign development, license agreement for short-acting glucagon program

High-phenolic-content olive oil modifies genes that promote inflammation

Literature review discusses herniated disks and treatment options for low back pain

MGH, Iacocca Foundation complete Phase I BCG clinical trial in type 1 diabetes

Rubella epidemic played a major role in shifting public attitudes toward abortion laws

Rosiglitazone associated with increased risk of serious cardiovascular events compared with pioglitazone

Hospira announces intention to complete tender offer for Javelin's outstanding common stock shares

Study finds no link between internet and gambling addictions, but affected individuals have common psychological profiles

Bicycling and brisk walking associated with less weight gain in obese, premenopausal women

APP to market Anastrozole 1 mg tablets in U.S.

Failed ACL surgeries are more common than previously thought

G8 nations commit $5B for maternal, child health; Additional $2.3B committed from other countries, foundations

EpiCept requests FDA priority review of Ceplene NDA for AML

Endometriosis can affect women's work productivity

BioAlliance Pharma presents abstracts on Loramyc, clonidine Lauriad at MASCC/ISOO 2010 symposium

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News